The APLAR 2020 preliminary program is now available!
To view the preliminary program below, please select on the specific day tab that you wish and the individual program will be shown.
The program is still under review and is subject to change.
Pre-Congress program
| Friday 23 October | ||||
| 1400-1700 | Pre-Congress workshop Biomechanics & Movement Workshop with BJC Health Brought to you by  |
|||
Main program
| 1000 – 1130 | Plenary session 1: Management of rheumatic diseases during the COVID-19 pandemic Speakers COVID-19 in rheumatology practice in Japan Tsutomu Takeuchi, Keio University School of Medicine, Japan TBA TBA |
|||
| 1130 – 1245 | Morning symposium 1 “Beyond remission” based on patients’ subjective experiences for improved RA control | Morning symposium 2 | Morning symposium 3 New evidence on the JAK inhibitor and its clinical implications for rheumatoid arthritis | Morning symposium 4 |
Brought to you by  | Brought to you by  | Brought to you by  | ||
| 1245 – 1315 | Break | |||
| 1315 – 1445 | Prospects for JAK inhibitors in the treatment of rheumatoid arthritis | Basic and Clinical of Rheumatology |
||
Brought to you by | Brought to you by |
|||
| 1500 – 1640 | SpA – 1: New advances in Axial Spondyloarthritis | SLE – 1: Progress and perspectives on SLE in the APLAR region | Imaging: Imaging in rheumatic diseases – where do we stand | Treating children with rheumatic diseases in Asia Pacific: The Great Divide |
| Chairpersons: Mitsumasa Kishimoto Katy Leung Nazrul Islam | Chairpersons: Sandra Navarra Yoshiya Tanaka | Chairpersons: Chi-Chen Chang Ved Chaturvedi | Chairpersons: Masaki Mori Surjit Singh |
|
| Outcome of Juvenile spondyloarthropathy in adulthood Amita Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India | Patient education as vital to improving outcomes Laniyati Hamijoyo, University of Padjadjaran, Indonesia | Ultrasound and its clinical use in rheumatoid arthritis Kei Ikeda, Chiba University Hospital, Japan | Asia-Pacific Pediatric Rheumatology: Where Do We Stand Sumaira Farman, National Hospital & Medical Center; Al-Aleem Medical College; Fatima Jinnah Medical University, Pakistan |
|
| Improving Access to Care in Resource Challenged Settings: Lessons from the Paediatric Task Force Global MSK Health Helen Foster, Newcastle University, United Kingdom |
||||
| Treat-to-Target in SpA, how far are we going? James Wei, Chung Shan Medical University Hospital, Taiwan | Progress and Perspectives on SLE in the APLAR region Evan Vista, St. Luke’s Medical Center and College of Medicine, Philippines | Ultrasound in large vessel vasculitis Kuo-Lung Lai, Taichung Veterans General Hospital, Taiwan | JIA: Geographic variability in treatment and long-term outcomes of JIA Soamarat Vilaiyuk, Mahidol University, Thailand |
|
| When and how to use, or not to use MRI in SpA” Ashish Jacob Mathew, Christian Medical College, India | Interim report of the APLAR consensus statements on the management of SLE Chi Chiu Mok, Tuen Mun Hospital, Hong Kong | MRI in Rheumatoid Arthritis Mami Tamai, Nagasaki University, Japan | Macrophage Activation Syndrome: Analysis of various Cytokines Masaki Shimizu, Tokyo Medcial And Dental University, Japan |
|
| Novel assessment tool for bony damage in spondyloarthritis Lai-shan Tam, The Chinese University of Hong Kong, Hong Kong | Ultrasound and its clinical use in spondyloarthropathy Lee Ka Wing Gavin Hong Kong | Autoinflammatory disorders: Spectrum seen in Asia Pacific Sulaiman Al-Mayouf, King Faisal Specialist Hospital & Research Center, Saudi Arabia |
||
| Updates on the Asia Pacific Lupus Collaboration (APLC) cohort Eric Morand, Australia | Vasculitis: Childhood onset Takayasu arteritis: an update Satish Kumar, Christian Medical College, India |
|||
| Panel Q&A | Panel Q&A | Panel Q&A | Panel Q&A | |
| 1640 – 1740 | Abstract session: IgG4-RD, AOSD/sJIA, Kawasaki disease | Abstract session: SLE and APL syndrome 1 | Abstract session: IIM, SSc, SjS | Abstract session: COVID-19 and CTD |
| Increased Human Neutrophil Lipocalin and its Clinical Relevance in Adult-Onset Still’s Disease Ji Li, Peking University International Hospital, China | Platelet Indices Could Be Simple, Reliable Predictors of Thrombotic Events in Patients with Antiphospholipid Syndrome Yu Shi, Peking Union Medical College, China | Clinical and swallowing outcomes in patients with dermatomyositis and polymyositis with dysphagia using the Food Intake LEVEL Scale Shin-ichiro Ohmura, Seirei Hamamatsu General Hospital, Japan | Rheumatic diseases on COVID-19 era Selma Abdellaoui, Beni Messous Hospital, Algeria |
|
| Different Immunophenotypes Characterized IgG4-Related Disease Clinical Phenotypes Eduardo Martín-Nares, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Mexico | Prevalence of celiac disease in patients with systemic lupus erythematosus Zahra Soltani, Tehran University of Medical Sciences, Iran | Immunomodulatory Therapy: a New Strategy for Dermatomyositis /Polymyositis Shengxiao Zhang, The Second Hospital of Shanxi Medical University, China | Prevalence of emotional disorder and sleep quality in patients with systemic lupus erythematosus during COVID-19 epidemic: a cross-sectional study Jing Zhu, Sichuan Provincial People’s Hospital, China |
|
| Abnormality of peripheral lymphocyte subsets in patients with Bechet’s disease and their restorations after receiving new immunomodulatory therapy Shengxiao Zhang, The Second Hospital of Shanxi Medical University, China | SLE Disease Activity Score (SLE-DAS) is a comparable disease activity measure to SLEDAI-2K Masanori Kono, University of Tokyo Hospital, Japan | Characteristics And Outcomes Of Overlap Myositis: A Comparative Multigroup Study In Adults And Children with Idiopathic Inflammatory Myopathies (IIM) Naveen R, Sanjay Gandhi Post Graduate Institute Of Medical Sciences, India | Factors associated with use of telemedicine for follow-up of lupus nepthritis in the COVID-19 outbreak Ho So, The Chinese University of Hong Kong, Hong Kong |
|
| Application Of Preliminary PRINTO Classification Criteria For SJIA In An Indian Cohort Devang Pandya, Dev Children’s Hospital, India | Development of a genetic risk score for Filipino patients with systemic lupus erythematosus Michael Tee, University of The Philippines, Philippines | Prognosis and Treatments of Patients with Myositis-associated Severe Interstitial Lung Disease: A Descriptive Study using National Inpatient Database in Japan Hiroki Furuya, Department of Allergy And Clinical Immunology, Japan | Spectrum Of Systemic Inflammatory Syndrome In Children During COVID 19 Pandemic In India Devang Pandya, Dev Children’s Hospital, India |
|
| Long-term outcome of 21 cases of giant coronary aneurysm after Kawasaki disease – Our 40 years’ experience Tomomi Sato, Shiga University of Medical Science, Japan | The Association between Serum Leptin Levels, Body Mass Index, and Disease Activity in Women with Systemic Lupus Erythematosus Nittayawadee Aeamsaard, Phramongkutklao Hospital and College of Medicine, Thailand | Nailfold Capillary Changes in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Tomohiro Sugimoto, Hiroshima University Hospital, Japan | Reactive arthritis after COVID-19 infection Keisuke Ono, Kyorin University School of Medicine, Japan |
|
| Immunophenotypic analysis of peripheral blood mononuclear cells in IgG4-Related Disease Aya Nishiwaki, The University of Tokyo, Japan | Joint Q&A | Is Rituximab an Adequate Glucocorticoid-Sparing Agent in Idiopathic Inflammatory Myopathies? Serdal Ugurlu, Istanbul University- Cerrahpasa, Turkey | A Healthy Dose of Skepticism: Eosinophilic Granulomatosis with Polyangiitis Initially Presenting as Possible COVID-19 Vincent Anthony Tang, University Of The Philippines – Philippine General Hospital, Philippines |
|
| TBA | Joint Q&A | Assessing the Impact on Heath Seeking Behavior During COVID-19 Outbreak in a Group of Rheumatology Patients from Sri Lanka Sunith Atukorale, Ministry of Health, Sri Lanka |
||
| Joint Q&A | Joint Q&A | |||
| 1740 – 1840 | Evening symposium 1 | Evening symposium 2 Treat-to-target in SLE: addressing short- and long-term treatment goals | Evening symposium 3 ILD in Focus: Time to prioritize the lung in CTDs | Evening symposium 4 Perspectives around the accumulated evidence for IL-6 in autoimmune disease |
| Brought to you by | Brought to you by  | Brought to you by  | Brought to you by  |
|
| 1000 – 1130 | Plenary session 2: Past, present and future of rheumatology Speakers: Rheumatology: A Crystal Gaze? – a future perspective Syed Haq, BSM Medical University, Bangladesh TBA Title TBA Ian McInnes, University of Glasgow, United Kingdom |
|||
| 1130 – 1245 | Morning symposium 5 Treatment of Rheumatoid Arthritis: Past and Future | Morning symposium 6 To continue, taper or discontinue biologics – Implications on RA treatment outcomes | Morning symposium 7 | Morning symposium 8 |
Brought to you by  | Brought to you by | |||
| 1245 – 1315 | Break | |||
| 1315 – 1445 | New insights for clinical practice in Spondyloarthritis, SpA Brought to you by  | New therapeutic alternatives for rheumatic diseases: Individualizing the treatment approach Brought to you by  |
||
| 1500 – 1640 | Vasculitis: Merge of basic and clinical researches of vasculitis | SLE – 2: SLE clinical | Genetics: recent progress in genetics of rheumatic diseases | SpA – 2: Updates in PsA |
| Chairpersons: Debashish Danda Xinping Tian Masayoshi Harigai | Chairpersons: Yoshiya Tanaka | Chairpersons: Michael Tee Zhanghou Li | Chairpersons: Atimichi Morita James Wei |
|
| TBA | Management of systemic lupus erythematosus (SLE) during and beyond the COVID-19 pandemic Sandra V. Navarra, University of Santo Tomas, Philippines | GWAS, eQTL and epigenome of rheumatic diseases Kazuhiko Yamamoto, RIKEN Center for Integrative Medical Sciences, Japan | Differential diagnosis of Psoriatic arthritis in daily practice Mitsumasa Kishimoto, Kyorin University School of Medicine, Japan |
|
| TBA | ||||
| Genetic analysis of Takayasu arteritis Ruchika Goel, Christian Medical College, India | Risk assessment and prevention of cardiovascular co-morbidities in psoriatic arthritis Lai-Shan Tam, The Chinese University of Hong Kong, Hong Kong |
|||
| TBA | Continuing challenges in lupus nephritis Daniel TM Chan, University of Hong Kong, Hong Kong | Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population Jianping Guo, Peking University People’s Hospital, China |
||
| Panel Q&A | ||||
| TBA | Special issues on pregnancy and lactation Aisha Lateef, Woodlands Health Campus, Singapore | Genetics of Kawasaki Disease: where are we in circa 2020 Surjit Singh, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education And Research, Chandigarh, India | Biomarker for PsA – myth or reality Katy Leung, Singapore General Hospital, Duke-nus Medical School, Singapore |
|
| TBA | ||||
| TBA | Genetic risk score Sarah Reid | TBA | ||
| Panel Q&A | Panel Q&A | Panel Q&A | ||
| 1640 – 1740 | Abstract session: IIM, SSc, SjS | Abstract session: SLE and APL syndrome 2 | Abstract session: OA and Crystal induced arthritis | Abstract session: SpA, AS-1 |
| Clinical Responses to Low-dose Interleukin-2 in Idiopathic Inflammatory Myopathies Miao Miao, Peking University People’s Hospital, China | Leukocyte immunoglobulin-like receptor A3 (LILRA3) promotes lupus-like disease severity Yundi Tang, Peking University People’s Hospital, China | The numeral changes of peripheral lymphocyte subsets in 238 patients with GOUT and their correlation analysis with disease activity Lijun Zhao, The Second Hospital of Shanxi Medical University, China | TBA | |
| Prediction of myocardial abnormalities in systemic sclerosis, assessed in cardiac magnetic resonance imaging, by using artificial neural networks models Masaki Haraoka, St. Marianna University School of Medicine, Japan | Should ophthalmologic evaluation be done as a screening test for new onset lupus patients with no eye complaint? Seyedeh Tahereh Faezi, Tehran University of Medical Sciences, Iran | Subtype Genome-Wide Meta-Analyses of Clinically-Defined Gout Revealed Multiple Subtype-Specific Gout Loci and Enrichment of Selection Pressure on ABCG2 and ALDH2 Yusuke Kawamura, National Defense Medical College, Japan | Efficacy and Safety of Brodalumab, Anti-IL-17 Receptor A Monoclonal Antibody, for Axial Spondyloarthritis, A 68-Week Result of Phase 3 Study Tae-Hwan Kim, Hanyang University Medical Center, Democratic Republic of Korea |
|
| Clinical analysis of dermatomyositis / polymyositis / cancer-associated myositis and related research on peripheral blood CD4 + T lymphocyte subsets Pan-di Zhang, The Second Hospital of Shanxi Medical University, China | TBA | Systematic Review and Meta-Analysis of the Prevalence of Neuropathic-Like Pain and Pain Sensitisation in People With Knee and Hip Osteoarthritis Luigi Zolio, Alfred Health, Australia | Improvements in Patient-Reported Outcomes in AS Patients Treated With Golimumab: Sub-Analysis of Asian Patients Enrolled in Phase III Clinical Trials Wen-Chan Tsai, Kaohsiung Medical University, Taiwan |
|
| Diagnostic Accuracy of Salivary Free Light Chain and Immunoglobulin Assays in Primary Sjögren’s Syndrome Pulukool Sandhya, St Stephens Hospital Delhi, India | Voclosporin Has Demonstrated Efficacy in Asian Patients With Lupus Nephritis Tatsuya Atsumi, Hokkaido University, Japan | A Randomised Placebo-controlled Clinical Trial of Curcuma Longa Extract for Treating Symptoms and Effusion-synovitis of Knee Osteoarthritis (CurKOA trial) Benny Samuel Eathakkattu Antony, University of Tasmania, Australia | Abnormality of peripheral lymphocyte subsets in patients with ankylosing spondylitis and restoration after receiving immunoregulatory combination therapies Shengxiao Zhang, The Second Hospital of Shanxi Medical University, China |
|
| The Artificial Intelligence for the Prediction of Focal Score of Labial Salivary Gland Biopsy in the Diagnosis of Sjogren Syndrome Nobooru Kitamura, Nihon University School of Medicine, Japan | Newly Diagnosed Lupus Nephritis in Elderly Predicts Good Renal Outcome: a Distinct Disease Subset from Young-onset Lupus Nephritis Kazuoto Hiramoto, Keio University School of Medicine, Japan | The Trajectory of Exercise Adherence Over Time and the Effect of Theory-lead Intervention for Knee Osteoarthritis in Elderly Limin Wang, Peking University, China | Comorbidity Profiles among patients with Axial Spondyloarthritis Fariz Yahya |
|
| Effects of Nintedanib in Asian Patients with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD): Subgroup Analysis of the SENSCIS Trial Masataka Kuwana, Nippon Medical School, Japan | Thrombotic risk assessment in patient with systemic lupus erythematosus: validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients Wanitcha Chanloung, Chiang Mai University, Thailand | The Prevalence and Incidence of Symptom Knee Osteoarthritis in the Middle-aged and Elderly: a National Survey from China Limin Wang, Peking University, China | Response to Certolizumab Pegol in Patients with Non-Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Cut-Offs: Post-Hoc Analysis from C-axSpAnd Philip Robinson, University of Queensland, Australia |
|
| Joint Q&A | Serological Evolution in Patients with Positive Antiphospholipid Antibodies-A Retrospective Study of Chinese Cohort Lanlan Ji, Peking University First Hospital, China | Prevalence and Clinical Features of Early-onset Osteoarthritis in a Large Scale Cross-sectional Study Jiajing Peng, Peking University People’s Hospital, China | Imbalance of Th17/Treg In Cardiovascular Diseases of Patients With Ankylosing Spondylitis Tingting Ding, The Second Hospital of Shanxi Medical University, China |
|
| Joint Q&A | Joint Q&A | Joint Q&A | ||
| 1740 – 1840 | Evening symposium 5 Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient | Evening symposium 6 The role of interleukin-6 in rheumatoid arthritis | Evening symposium 7 Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies | Evening symposium 8 |
Brought to you by  | Brought to you by  | Brought to you by | ||
Text | Text | Text | ||
Test | ||||
TEST |